Is It Possible to Increase Penile Length? The Honest Science in 2026
Introduction: The Question Deserves a Real Answer
The question is asked far more often than it is spoken aloud. Men who have built careers, families, and reputations on making evidence-based decisions often find themselves searching quietly for an answer that no one seems willing to give them straight. There is nothing embarrassing about the question. It is a clinically legitimate one, and it deserves a clinical answer.
This article will not rely on anecdote, marketing hype, or forum speculation. Instead, it draws directly from randomized controlled trials (RCTs), position statements from the American Urological Association (AUA) and the Sexual Medicine Society of North America (SMSNA), and peer-reviewed satisfaction data. The goal is honesty, not persuasion.
This piece will examine what the science actually says about increasing penile length, which methods have credible evidence and which do not, what the satisfaction data reveals about the men who pursue these procedures, and where the evidence ultimately points as the superior option.
A reframe is worth planting early. The answer to “can I increase penile length?” is more nuanced than a simple yes or no. Once the satisfaction data enters the picture, the more useful question often changes entirely.
This is also an actively evolving clinical conversation. In May 2026, the AUA held a dedicated plenary session titled “Can You Truly Lengthen a Penis?” The fact that the field’s leading professional body is still debating the question tells the reader something important: certainty here is earned through data, not claims.
What Science Says About Average Penile Size (And Why It Matters First)
Before evaluating any method, the baseline matters. According to NIH-referenced data, the clinically accepted average erect penile length is approximately 5.1 to 5.5 inches (12.95 to 13.97 cm). The SMSNA’s 2024 position statement makes an even more striking point: the majority of men seeking enhancement have clinically normal-sized penises.
The disconnect comes from perception. Most men believe the average erect penis is around 6 inches (15.2 cm), well above the actual clinical average. That gap is fueled in large part by pornography and social media, which present outliers as the norm.
The perceptual problem runs deeper still. A 2025 study from Peking University, published in Sexual Medicine, found that men systematically underestimate their own erect length when they self-measure in the flaccid state. In other words, the anxiety is frequently rooted in a measurement illusion, not an anatomical reality.
This matters because if the starting premise is distorted, the urgency of the question changes. That said, acknowledging the perceptual bias does not invalidate the question for men who still want to explore their options.
There is also a psychological dimension worth naming honestly. EAU 2023 guidelines report that 2.2% of US men meet criteria for Body Dysmorphic Disorder (BDD), with a subset presenting with Penile Dysmorphic Disorder (PDD). Peer-reviewed research indicates that roughly 11 to 14% of men seeking augmentation meet BDD diagnostic criteria. A responsible provider takes this seriously.
With that baseline established, the actual methods can be evaluated.
Methods That Do NOT Have Credible Evidence for Permanent Length Increase
The professional reader does not need lengthy debunking, only clear conclusions with the science behind them.
- Pills and supplements: There is no RCT evidence for permanent length increase and no credible biological mechanism by which an oral supplement could produce structural tissue growth. This category is marketing, not medicine.
- Jelqing: There is no peer-reviewed RCT evidence supporting this manual technique. There is, however, documented potential for injury, including fibrosis and Peyronie’s-like scarring.
- Vacuum erection devices (pumps): These are medically validated for erectile dysfunction rehabilitation and temporary engorgement. They are not validated for permanent enlargement. That distinction is critical and often deliberately blurred by sellers.
Notably, most reputable institutional content stops here. It lists what does not work, notes surgical risks, and offers no validated alternative. This article will not leave the reader in that dead end.
The One Non-Surgical Method With RCT Evidence: Penile Traction Therapy
Penile traction therapy (PTT) is the only non-surgical method with randomized controlled trial evidence for length increase. That distinction alone separates it from every option in the previous section.
The evidence is specific. An RCT published in the Journal of Urology found that the RestoreX device produced a mean 1.6 cm increase in stretched penile length at 6 months in post-prostatectomy men, compared to no change in controls. A second RCT of 110 men with Peyronie’s disease found that RestoreX produced a 1.5 cm increase in penile length and an 11.7-degree reduction in curvature versus controls at 3 months, with 94% of treated men achieving some length increase.
Honesty requires stating the boundary clearly: the strongest PTT evidence is in men with Peyronie’s disease or post-prostatectomy length loss. Evidence for meaningful length gains in otherwise healthy men without these conditions remains limited.
There is also a compliance reality. Traditional traction required 2 to 9 hours of daily use, a barrier most men could not sustain. Newer devices like RestoreX report results with approximately 30 minutes per day, a meaningful improvement.
An experimental frontier exists as well. The P-Long Protocol, which combines PRP injections, traction, vacuum therapy, and a nitric oxide supplement, showed a promising increase of roughly 0.81 inch (about 2 cm) in a 2024 study. It remains experimental. An active 2026 ClinicalTrials.gov study (NCT07053826) is currently evaluating RestoreX PTT before penile prosthesis implantation, signaling continued scientific investment.
The honest bottom line: PTT is the most credible non-surgical option, but realistic gains are modest (1 to 2 cm), results are strongest in specific clinical populations, and daily compliance is required.
Surgical Penile Lengthening: What the Procedures Are and What the Data Actually Show
The most commonly performed surgical lengthening procedure is suspensory ligament division (SLD), also called ligamentolysis. It works by releasing the ligament that anchors the penis to the pubic bone.
The anatomical reality is frequently misunderstood. SLD increases flaccid (non-erect) length. Erect functional length gain is far less certain, and dividing the ligament can introduce instability during erection.
The AUA’s position could not be more direct. Its position statement, originally issued in 1994 and reaffirmed most recently in 2018, considers SLD to be a procedure that “has not been shown to be safe or efficacious.” That position has been held continuously for more than 30 years.
The 2026 AUA plenary added nuance. Ligamentolysis combined with a spacer and V-Y plasty can increase stretched penile length by up to 3.5 cm. However, erect functional length gain, which is what most patients actually want, remains uncertain. A 2024 systematic review in Translational Andrology and Urology concluded that evidence for penile lengthening procedures is “limited due to the short of case series reported, lack of randomized controlled trials, and heterogeneity of the studies.”
Other surgical approaches, including graft-and-flap procedures, silicone sleeve implants, and sliding or slicing techniques, were addressed in the 2024 SMSNA position statement. All carry significant risk profiles. Documented complications include scarring, infection, hematoma, temporary or permanent numbness, erectile dysfunction, and paradoxical penile shortening caused by scar tissue formation.
Which leads to the single most important data point in this article.
The Satisfaction Data: Why 65 to 73% of Men Who Get Length Surgery Regret It
A landmark study in European Urology found that only 35% of patients were satisfied with the outcome of suspensory ligament division surgery. In men with penile dysmorphic disorder, the very population most likely to seek the procedure, satisfaction dropped to 27%.
A 2017 review in Translational Andrology and Urology confirmed the pattern, finding satisfaction rates ranging from just 30 to 65% across studies.
For a professional reader accustomed to weighing risk against reward, the implication is stark. This is a procedure with a majority dissatisfaction rate, irreversible risks, and no AUA endorsement. In virtually any other elective medical context, that risk/reward profile would be considered unacceptable.
The psychological layer compounds the problem. Peer-reviewed research shows that men with higher penile dysmorphic disorder symptoms and lower self-esteem are the most likely to seek surgery and the least likely to be satisfied by it. The procedure does not resolve the underlying dissatisfaction.
So if surgical lengthening delivers roughly 35% satisfaction, and if the research consistently links a different dimension to sexual satisfaction, the honest next question becomes: what does the evidence say about girth? For a direct comparison of these two approaches, the evidence on penis filler vs surgical phalloplasty makes the tradeoffs clear.
The Evidence Pivot: Why Girth Is the Dimension That Actually Drives Sexual Satisfaction
The data here is remarkably consistent. One frequently cited survey found that 45 of 50 women (90%) prioritized width over length when asked about sexual satisfaction. A methodologically rigorous 2015 PLOS ONE study using 3D-printed models found that women preferred above-average girth for one-time partners.
The anatomical explanation is straightforward. Vaginal nerve endings are concentrated in the outer third, and girth produces more consistent stimulation of these structures than length does.
This is not about dismissing a man’s original question. It is about following the evidence to where satisfaction actually lives, and the evidence points toward girth.
Penile Girth Augmentation With Hyaluronic Acid Fillers: The Evidence in 2026
Girth augmentation with hyaluronic acid (HA) fillers has the strongest satisfaction data of any penile enhancement procedure.
The evidence is recent and robust. A 2025 single-center study in the Journal of Sexual Medicine of 328 men reported 89% patient satisfaction, a mean 2.5 cm increase in flaccid girth, and no serious adverse events over a mean 9-month follow-up. A 2024 UroFill study in the same journal, involving 300 men, reported 91% satisfaction (“completely” or “mostly satisfied”), 90% filler retention at 12 months, and no erectile dysfunction or penile sensation loss. A 2025 ultrasound-guided HA study in Plastic and Reconstructive Surgery: Global Open documented increased midshaft circumference from 12.3 to 13.0 cm, with high patient satisfaction, improved self-confidence, and only transient minor adverse events.
The professional bodies concur on materials. EAU 2023 guidelines explicitly identify HA as an evidence-supported injectable for girth enhancement, while advising against silicone, paraffin, and Vaseline injections. The 2024 SMSNA position statement acknowledges injectable fillers as part of the evolving cosmetic penile enhancement landscape.
Two advantages deserve emphasis. First, reversibility: hyaluronic acid penile filler biocompatibility and the ability to dissolve HA with hyaluronidase represent a fundamentally different risk profile than irreversible surgical lengthening. Second, the satisfaction contrast is the single most persuasive data point in this article. Surgical lengthening delivers roughly 35% satisfaction, while HA girth augmentation delivers 89 to 91%.
A Free Option Worth Knowing: Suprapubic Fat and Hidden Penile Length
Before any procedure, there is a zero-cost, zero-risk consideration almost entirely absent from institutional content.
Excess suprapubic fat, the tissue over the pubic mound, can bury 1 to 2 cm of penile shaft. This makes the functional visible length shorter than the actual anatomical length. Weight loss or targeted lipectomy can reveal this hidden length without any procedure, any risk, or any cost.
This is not a procedure. It is a body composition consideration. For some men, it may be the single most impactful and safest path available. For men who have already addressed this, or for whom it does not apply, professional girth augmentation represents the evidence-superior next step.
Who Is a Good Candidate for Girth Augmentation, and Who Should Pause First
The ideal candidate is a generally healthy man with realistic expectations, clinically normal anatomy, and a desire for moderate, natural-looking enhancement. Understanding realistic expectations for girth enhancement results is an important part of the evaluation process.
Screening matters. SMSNA and EAU guidelines recommend psychological evaluation before augmentation for men showing signs of BDD or PDD. Given that roughly 11 to 14% of men seeking augmentation meet BDD diagnostic criteria, a reputable provider screens for this rather than ignoring it. A provider who recommends psychological evaluation before proceeding is demonstrating clinical seriousness, not discouraging the patient.
Men with active infections, bleeding disorders, or unrealistic expectations are not appropriate candidates. Honesty at the consultation stage protects everyone.
What to Look for in a Girth Augmentation Provider
- A board-certified physician with documented experience specifically in penile filler placement, not a general aesthetics injector.
- Transparent use of medical-grade, biocompatible materials, meaning HA fillers with published safety data.
- Hospital-grade sterility protocols, because this is a sensitive anatomical area with real infection risk.
- A staged treatment approach: incremental sessions rather than a single dramatic procedure, which reduces risk and allows for symmetry correction.
- A comprehensive consultation process including realistic expectation-setting, informed consent, and clear aftercare protocols.
- Willingness to discuss reversibility (hyaluronidase dissolution) and what happens if the patient is unsatisfied.
- Explicit avoidance of materials with poor safety profiles (silicone, paraffin, and Vaseline, all contraindicated by EAU 2023 guidelines).
- Volume of experience: a provider who has performed thousands of procedures has encountered and managed the full range of anatomical variation and post-procedure scenarios.
Penile Girth Augmentation at Stoller Medical Group: The Clinical Approach
Stoller Medical Group, operating as Penis Enlargement New York City, is a specialized practice that has performed over 15,000 enlargement procedures, one of the highest documented volumes in the United States.
The practice is led by Dr. Roy B. Stoller, a board-certified physician with more than 25 years in aesthetic and restorative medicine and 5 years dedicated specifically to non-surgical male enhancement.
The primary procedure is filler phalloplasty using Belefil®, a hyaluronic acid-based dermal filler that is medical-grade and biocompatible, consistent with the injectable categories the EAU endorses. The procedure profile is straightforward: non-surgical, no cutting, no general anesthesia, performed on an outpatient basis, and completed in under one hour.
Results are meaningful and measured. Patients can achieve up to 1 to 1.5 inches of increase in girth, with 80 to 90% permanent improvement in girth and volume. Results are visible immediately, look and feel natural in both flaccid and erect states, and preserve normal sensation and function. The recovery advantage is notable: patients are back on their feet in 10 days (compared to 40 or more days with other permanent fillers), with sexual activity resuming within 7 to 10 days.
The practice uses a staged treatment protocol, favoring multiple sessions over a single dramatic procedure. This reduces risk, improves symmetry, and allows for customization. Glans enlargement and scrotal enhancement can be performed simultaneously if desired.
With five locations across Manhattan, Long Island, and Albany in New York, plus Chadds Ford, Pennsylvania, and Eagan, Minnesota, the practice offers geographic accessibility for a regional patient base.
Importantly, the practice explicitly does not offer surgical penile lengthening. That is a deliberate, safety-first decision, and it aligns precisely with both the AUA position statements and the satisfaction data reviewed throughout this article. Free consultations are available.
Understanding the Investment: Pricing and What to Expect
Girth augmentation at Stoller Medical Group is priced by syringe, a transparent, volume-based model that allows for individual customization.
Procedures start at $7,500 and increase depending on the desired result and individual anatomy. Most men begin with a minimum of 10 syringes, and the average first procedure involves approximately 15 syringes.
Context matters when evaluating this investment. This is a specialized, physician-performed procedure using medical-grade materials, with a satisfaction rate in peer-reviewed literature of roughly 91%. It is not a commodity service.
For the target reader, a professional accustomed to weighing cost against outcome certainty, the relevant comparison is not price alone. It is price relative to the likelihood of a satisfying result. On that measure, the data strongly favors HA girth augmentation over surgical alternatives. Surgical lengthening carries a 35% satisfaction rate and irreversible risk, making cost a secondary concern in that comparison. Free consultations allow prospective patients to discuss their specific anatomy, goals, and expected syringe volume before committing to anything.
Conclusion: What the Science Actually Tells You
The honest verdict on penile length increase is this: penile traction therapy is the only non-surgical method with RCT evidence, and its gains are modest (1 to 2 cm), strongest in specific clinical populations, and dependent on daily compliance. Surgical lengthening carries irreversible risks, has no AUA endorsement after more than 30 years, and produces only a roughly 35% satisfaction rate.
The pivot is clear. The evidence does not support length surgery as a reliable path to satisfaction. It does strongly support girth augmentation with HA fillers, which demonstrates 89 to 91% satisfaction in peer-reviewed studies.
The perceptual dimension deserves a final acknowledgment. Many men seeking enhancement have clinically normal anatomy and are affected by a documented measurement bias. A reputable provider addresses that honestly before proceeding, rather than exploiting it.
The question “is it possible to increase penile length?” has a nuanced, honest answer. Following that answer to its logical conclusion leads to girth augmentation as the evidence-superior, satisfaction-correlated, lower-risk option. Men who have read this far deserve a consultation with a provider who will give them the same level of clinical honesty this article has, not a sales pitch.
Ready to Explore Your Options? Schedule a Free Consultation
Men ready to take the next step can schedule a free, fully confidential consultation with Stoller Medical Group at any of five locations: Manhattan, Long Island, or Albany in New York; Chadds Ford in Pennsylvania; or Eagan in Minnesota.
Discretion is prioritized at every stage. During the consultation, patients receive a personalized anatomical assessment, realistic goal-setting, a transparent discussion of syringe volume and pricing, and a clear explanation of the staged treatment approach.
Dr. Stoller and the clinical team have performed over 15,000 procedures. Patients are not a test case; they are benefiting from one of the most experienced practices in the country. Procedures start at $7,500, with most men beginning at a minimum of 10 syringes and an average first procedure of approximately 15 syringes. A free consultation is the first step to understanding what is right for an individual’s anatomy and goals.
Professionals who take a data-driven approach to every other decision in their lives deserve that same standard when it comes to their health and confidence.
